SANDRA GATES-MANNA: Open Payments
NPI 1124396072 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 61 payments from 15 companies in 2025. Trend: 2023 $1,439 · 2024 $2,625 · 2025 $2,415
Food & beverage: $2,415
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $518 |
| Axsome Therapeutics, Inc. | 6 | $358 |
| ABBVIE INC. | 4 | $273 |
| Abbott Laboratories | 15 | $253 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $235 |
| Novo Nordisk Inc | 4 | $160 |
| Eisai Inc. | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| E.R. Squibb & Sons, L.L.C. | 1 | $89 |
Products named: AIRSUPRA, Auvelity, FREESTYLE LIBRE 3, VRAYLAR, CAPLYTA, Leqembi, Ozempic, ZORYVE.
Industry payments across IN — which companies pay providers there.
